Click for best price
Botanical Drug Market Size, Share 2024
| Market size in 2023 |
US$ 33630 million
|
Forecast Market size by 2030 |
US$ 43740 million
|
| Growth Rate |
CAGR of 39.2% |
Number of Pages |
101 Pages |
The global Botanical Drug market was valued at US$ 33630 million in 2023 and is projected to reach US$ 43740 million by 2030, at a CAGR of 39.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Botanical Drug market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Botanical Drug market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Botanical Drug market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Sales outsourcing is simply this: outsourcing a portion or entire sales activities to a trusted 3rd party sales team. Using a sales outsourcing partner allows companies to attract and maintain a sales force without having to make them full or part-time employees.
This report aims to provide a comprehensive presentation of the global market for Botanical Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Botanical Drug. This report contains market size and forecasts of Botanical Drug in global, including the following market information:
- Global Botanical Drug Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2023 (%)
Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, etc. are the leaders of the industry.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 75% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 16%.
The classification of Botanical Drug includes Prescription Drug and OTC, and the proportion of OTC in 2019 was about 61%.
Botanical Drug is widely used for Cardiovascular, Tumor, Respiratory System, Others. The most proportion of Botanical Drug is Cardiovascular, and the proportion in 2019 was 30%.
We surveyed the Botanical Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Botanical Drug Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Botanical Drug Market Segment Percentages, by Type, 2023 (%)
Global Botanical Drug Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Botanical Drug Market Segment Percentages, by Application, 2023 (%)
- Cardiovascular
- Tumor
- Respiratory System
- Others
Global Botanical Drug Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Botanical Drug Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Botanical Drug revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Botanical Drug revenues share in global market, 2023 (%)
key players include:
- Buchang Pharmaceuticals
- China TCM
- Tsumura
- Schwabe
- Tong Ren Tang
- Jumpcan Pharmaceutical
- Guangzhou Baiyunshan Pharmaceutical
- Yunnan Baiyao
- Tasly Holding Group
- Bionorica Se
- Huarun 999
- Taiji
- Weleda
- Kwangdong
- GW Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Botanical Drug, market overview.
Chapter 2: Global Botanical Drug market size in revenue.
Chapter 3: Detailed analysis of Botanical Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Botanical Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Botanical Drug Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 33630 million
|
| Forecast Market size by 2030 |
US$ 43740 million
|
| Growth Rate |
CAGR of 39.2% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
101 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Botanical Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Botanical Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Botanical Drug Overall Market Size
2.1 Global Botanical Drug Market Size: 2022 VS 2029
2.2 Global Botanical Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Botanical Drug Players in Global Market
3.2 Top Global Botanical Drug Companies Ranked by Revenue
3.3 Global Botanical Drug Revenue by Companies
3.4 Top 3 and Top 5 Botanical Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Botanical Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Botanical Drug Players in Global Market
3.6.1 List of Global Tier 1 Botanical Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Botanical Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Botanical Drug Market Size Markets, 2022 & 2029
4.1.2 Prescription Drug
4.1.3 OTC
4.2 By Type - Global Botanical Drug Revenue & Forecasts
4.2.1 By Type - Global Botanical Drug Revenue, 2018-2023
4.2.2 By Type - Global Botanical Drug Revenue, 2024-2029
4.2.3 By Type - Global Botanical Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Botanical Drug Market Size, 2022 & 2029
5.1.2 Cardiovascular
5.1.3 Tumor
5.1.4 Respiratory System
5.1.5 Others
5.2 By Application - Global Botanical Drug Revenue & Forecasts
5.2.1 By Application - Global Botanical Drug Revenue, 2018-2023
5.2.2 By Application - Global Botanical Drug Revenue, 2024-2029
5.2.3 By Application - Global Botanical Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Botanical Drug Market Size, 2022 & 2029
6.2 By Region - Global Botanical Drug Revenue & Forecasts
6.2.1 By Region - Global Botanical Drug Revenue, 2018-2023
6.2.2 By Region - Global Botanical Drug Revenue, 2024-2029
6.2.3 By Region - Global Botanical Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Botanical Drug Revenue, 2018-2029
6.3.2 US Botanical Drug Market Size, 2018-2029
6.3.3 Canada Botanical Drug Market Size, 2018-2029
6.3.4 Mexico Botanical Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Botanical Drug Revenue, 2018-2029
6.4.2 Germany Botanical Drug Market Size, 2018-2029
6.4.3 France Botanical Drug Market Size, 2018-2029
6.4.4 U.K. Botanical Drug Market Size, 2018-2029
6.4.5 Italy Botanical Drug Market Size, 2018-2029
6.4.6 Russia Botanical Drug Market Size, 2018-2029
6.4.7 Nordic Countries Botanical Drug Market Size, 2018-2029
6.4.8 Benelux Botanical Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Botanical Drug Revenue, 2018-2029
6.5.2 China Botanical Drug Market Size, 2018-2029
6.5.3 Japan Botanical Drug Market Size, 2018-2029
6.5.4 South Korea Botanical Drug Market Size, 2018-2029
6.5.5 Southeast Asia Botanical Drug Market Size, 2018-2029
6.5.6 India Botanical Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Botanical Drug Revenue, 2018-2029
6.6.2 Brazil Botanical Drug Market Size, 2018-2029
6.6.3 Argentina Botanical Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Botanical Drug Revenue, 2018-2029
6.7.2 Turkey Botanical Drug Market Size, 2018-2029
6.7.3 Israel Botanical Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Botanical Drug Market Size, 2018-2029
6.7.5 UAE Botanical Drug Market Size, 2018-2029
7 Botanical Drug Companies Profiles
7.1 Buchang Pharmaceuticals
7.1.1 Buchang Pharmaceuticals Company Summary
7.1.2 Buchang Pharmaceuticals Business Overview
7.1.3 Buchang Pharmaceuticals Botanical Drug Major Product Offerings
7.1.4 Buchang Pharmaceuticals Botanical Drug Revenue in Global Market (2018-2023)
7.1.5 Buchang Pharmaceuticals Key News & Latest Developments
7.2 China TCM
7.2.1 China TCM Company Summary
7.2.2 China TCM Business Overview
7.2.3 China TCM Botanical Drug Major Product Offerings
7.2.4 China TCM Botanical Drug Revenue in Global Market (2018-2023)
7.2.5 China TCM Key News & Latest Developments
7.3 Tsumura
7.3.1 Tsumura Company Summary
7.3.2 Tsumura Business Overview
7.3.3 Tsumura Botanical Drug Major Product Offerings
7.3.4 Tsumura Botanical Drug Revenue in Global Market (2018-2023)
7.3.5 Tsumura Key News & Latest Developments
7.4 Schwabe
7.4.1 Schwabe Company Summary
7.4.2 Schwabe Business Overview
7.4.3 Schwabe Botanical Drug Major Product Offerings
7.4.4 Schwabe Botanical Drug Revenue in Global Market (2018-2023)
7.4.5 Schwabe Key News & Latest Developments
7.5 Tong Ren Tang
7.5.1 Tong Ren Tang Company Summary
7.5.2 Tong Ren Tang Business Overview
7.5.3 Tong Ren Tang Botanical Drug Major Product Offerings
7.5.4 Tong Ren Tang Botanical Drug Revenue in Global Market (2018-2023)
7.5.5 Tong Ren Tang Key News & Latest Developments
7.6 Jumpcan Pharmaceutical
7.6.1 Jumpcan Pharmaceutical Company Summary
7.6.2 Jumpcan Pharmaceutical Business Overview
7.6.3 Jumpcan Pharmaceutical Botanical Drug Major Product Offerings
7.6.4 Jumpcan Pharmaceutical Botanical Drug Revenue in Global Market (2018-2023)
7.6.5 Jumpcan Pharmaceutical Key News & Latest Developments
7.7 Guangzhou Baiyunshan Pharmaceutical
7.7.1 Guangzhou Baiyunshan Pharmaceutical Company Summary
7.7.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
7.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Major Product Offerings
7.7.4 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue in Global Market (2018-2023)
7.7.5 Guangzhou Baiyunshan Pharmaceutical Key News & Latest Developments
7.8 Yunnan Baiyao
7.8.1 Yunnan Baiyao Company Summary
7.8.2 Yunnan Baiyao Business Overview
7.8.3 Yunnan Baiyao Botanical Drug Major Product Offerings
7.8.4 Yunnan Baiyao Botanical Drug Revenue in Global Market (2018-2023)
7.8.5 Yunnan Baiyao Key News & Latest Developments
7.9 Tasly Holding Group
7.9.1 Tasly Holding Group Company Summary
7.9.2 Tasly Holding Group Business Overview
7.9.3 Tasly Holding Group Botanical Drug Major Product Offerings
7.9.4 Tasly Holding Group Botanical Drug Revenue in Global Market (2018-2023)
7.9.5 Tasly Holding Group Key News & Latest Developments
7.10 Bionorica Se
7.10.1 Bionorica Se Company Summary
7.10.2 Bionorica Se Business Overview
7.10.3 Bionorica Se Botanical Drug Major Product Offerings
7.10.4 Bionorica Se Botanical Drug Revenue in Global Market (2018-2023)
7.10.5 Bionorica Se Key News & Latest Developments
7.11 Huarun 999
7.11.1 Huarun 999 Company Summary
7.11.2 Huarun 999 Business Overview
7.11.3 Huarun 999 Botanical Drug Major Product Offerings
7.11.4 Huarun 999 Botanical Drug Revenue in Global Market (2018-2023)
7.11.5 Huarun 999 Key News & Latest Developments
7.12 Taiji
7.12.1 Taiji Company Summary
7.12.2 Taiji Business Overview
7.12.3 Taiji Botanical Drug Major Product Offerings
7.12.4 Taiji Botanical Drug Revenue in Global Market (2018-2023)
7.12.5 Taiji Key News & Latest Developments
7.13 Weleda
7.13.1 Weleda Company Summary
7.13.2 Weleda Business Overview
7.13.3 Weleda Botanical Drug Major Product Offerings
7.13.4 Weleda Botanical Drug Revenue in Global Market (2018-2023)
7.13.5 Weleda Key News & Latest Developments
7.14 Kwangdong
7.14.1 Kwangdong Company Summary
7.14.2 Kwangdong Business Overview
7.14.3 Kwangdong Botanical Drug Major Product Offerings
7.14.4 Kwangdong Botanical Drug Revenue in Global Market (2018-2023)
7.14.5 Kwangdong Key News & Latest Developments
7.15 GW Pharmaceuticals
7.15.1 GW Pharmaceuticals Company Summary
7.15.2 GW Pharmaceuticals Business Overview
7.15.3 GW Pharmaceuticals Botanical Drug Major Product Offerings
7.15.4 GW Pharmaceuticals Botanical Drug Revenue in Global Market (2018-2023)
7.15.5 GW Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Botanical Drug Market Opportunities & Trends in Global Market
Table 2. Botanical Drug Market Drivers in Global Market
Table 3. Botanical Drug Market Restraints in Global Market
Table 4. Key Players of Botanical Drug in Global Market
Table 5. Top Botanical Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Botanical Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Botanical Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Botanical Drug Product Type
Table 9. List of Global Tier 1 Botanical Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Botanical Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Botanical Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Botanical Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Botanical Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Botanical Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Botanical Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Botanical Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Botanical Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Botanical Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Botanical Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Botanical Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Botanical Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Botanical Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Botanical Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Botanical Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Botanical Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Botanical Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Botanical Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Botanical Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Botanical Drug Revenue, (US$, Mn), 2024-2029
Table 30. Buchang Pharmaceuticals Company Summary
Table 31. Buchang Pharmaceuticals Botanical Drug Product Offerings
Table 32. Buchang Pharmaceuticals Botanical Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Buchang Pharmaceuticals Key News & Latest Developments
Table 34. China TCM Company Summary
Table 35. China TCM Botanical Drug Product Offerings
Table 36. China TCM Botanical Drug Revenue (US$, Mn) & (2018-2023)
Table 37. China TCM Key News & Latest Developments
Table 38. Tsumura Company Summary
Table 39. Tsumura Botanical Drug Product Offerings
Table 40. Tsumura Botanical Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Tsumura Key News & Latest Developments
Table 42. Schwabe Company Summary
Table 43. Schwabe Botanical Drug Product Offerings
Table 44. Schwabe Botanical Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Schwabe Key News & Latest Developments
Table 46. Tong Ren Tang Company Summary
Table 47. Tong Ren Tang Botanical Drug Product Offerings
Table 48. Tong Ren Tang Botanical Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Tong Ren Tang Key News & Latest Developments
Table 50. Jumpcan Pharmaceutical Company Summary
Table 51. Jumpcan Pharmaceutical Botanical Drug Product Offerings
Table 52. Jumpcan Pharmaceutical Botanical Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Jumpcan Pharmaceutical Key News & Latest Developments
Table 54. Guangzhou Baiyunshan Pharmaceutical Company Summary
Table 55. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product Offerings
Table 56. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Guangzhou Baiyunshan Pharmaceutical Key News & Latest Developments
Table 58. Yunnan Baiyao Company Summary
Table 59. Yunnan Baiyao Botanical Drug Product Offerings
Table 60. Yunnan Baiyao Botanical Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Yunnan Baiyao Key News & Latest Developments
Table 62. Tasly Holding Group Company Summary
Table 63. Tasly Holding Group Botanical Drug Product Offerings
Table 64. Tasly Holding Group Botanical Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Tasly Holding Group Key News & Latest Developments
Table 66. Bionorica Se Company Summary
Table 67. Bionorica Se Botanical Drug Product Offerings
Table 68. Bionorica Se Botanical Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Bionorica Se Key News & Latest Developments
Table 70. Huarun 999 Company Summary
Table 71. Huarun 999 Botanical Drug Product Offerings
Table 72. Huarun 999 Botanical Drug Revenue (US$, Mn) & (2018-2023)
Table 73. Huarun 999 Key News & Latest Developments
Table 74. Taiji Company Summary
Table 75. Taiji Botanical Drug Product Offerings
Table 76. Taiji Botanical Drug Revenue (US$, Mn) & (2018-2023)
Table 77. Taiji Key News & Latest Developments
Table 78. Weleda Company Summary
Table 79. Weleda Botanical Drug Product Offerings
Table 80. Weleda Botanical Drug Revenue (US$, Mn) & (2018-2023)
Table 81. Weleda Key News & Latest Developments
Table 82. Kwangdong Company Summary
Table 83. Kwangdong Botanical Drug Product Offerings
Table 84. Kwangdong Botanical Drug Revenue (US$, Mn) & (2018-2023)
Table 85. Kwangdong Key News & Latest Developments
Table 86. GW Pharmaceuticals Company Summary
Table 87. GW Pharmaceuticals Botanical Drug Product Offerings
Table 88. GW Pharmaceuticals Botanical Drug Revenue (US$, Mn) & (2018-2023)
Table 89. GW Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Botanical Drug Segment by Type in 2022
Figure 2. Botanical Drug Segment by Application in 2022
Figure 3. Global Botanical Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Botanical Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Botanical Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Botanical Drug Revenue in 2022
Figure 8. By Type - Global Botanical Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Botanical Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Botanical Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Botanical Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Botanical Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Botanical Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Botanical Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Botanical Drug Revenue Market Share, 2018-2029
Figure 16. US Botanical Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Botanical Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Botanical Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Botanical Drug Revenue Market Share, 2018-2029
Figure 20. Germany Botanical Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Botanical Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Botanical Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Botanical Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Botanical Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Botanical Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Botanical Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Botanical Drug Revenue Market Share, 2018-2029
Figure 28. China Botanical Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Botanical Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Botanical Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Botanical Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Botanical Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Botanical Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Botanical Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Botanical Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Botanical Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Botanical Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Botanical Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Botanical Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Botanical Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Buchang Pharmaceuticals Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. China TCM Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Tsumura Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Schwabe Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Tong Ren Tang Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Jumpcan Pharmaceutical Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Yunnan Baiyao Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Tasly Holding Group Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bionorica Se Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Huarun 999 Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Taiji Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Weleda Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Kwangdong Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. GW Pharmaceuticals Botanical Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
